White label ELPA - ClinicalTrials.eu

Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

Not recruiting

3 1 1 1
Investigated Drugs:
- Epoetin Alfa
Study of Injectable Cabotegravir Compared to Oral Emtricitabine/Tenofovir for HIV Prevention in Men Who Have Sex with Men

Not recruiting

3 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Not recruiting

3 1
Investigated Drugs:
- Sotatercept
+7
Study on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough

Not recruiting

3 1
Investigated Drugs:
- Camlipixant
Study on the Effectiveness and Safety of Intranasal BPL-003 for Patients with Treatment-Resistant Depression

Not recruiting

2 1 1
Investigated Diseases:
- Major depression
Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

Not recruiting

3 1 1 1
Investigated Drugs:
- Irbesartan
- Sparsentan
+6
Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

Not recruiting

3 1 1
Investigated Drugs:
- Etrasimod Arginine
+8
Study on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder

Not recruiting

2 1
Investigated Diseases:
- Major depression
Investigated Drugs:
- Nelivaptan
+1
Study on the Effectiveness and Safety of Danicopan for Adults with Chronic Spontaneous Urticaria Resistant to H1-Antihistamines

Not recruiting

2 1 1 1
Investigated Diseases:
- Chronic spontaneous urticaria
Investigated Drugs:
Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
- Buparlisib
- Paclitaxel
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies